Pub Date : 2012-10-01DOI: 10.1016/S1576-9895(12)70159-5
M.L. Estévez , C. Pinedo , M. Rodríguez Masi , I. Guerassimova , P. Benedetti , B. Cabeza , G. Rodríguez Trigo
The term histiocytosis refers to a heterogeneous group of diseases characterized by the infiltration of Langerhans cells (LC) in different organs. Pulmonary Histiocytosis (PH) is an uncommon disease that typically affects young adults. Its pathogeny is not well known, although a relationship with smoking has been observed. Thus, the first treatment measure should be smoking cessation. We present a case of pulmonary histiocytosis that showed a favorable clinical, functional and radiological course in six months as a consequence of using smoking cessation as the only treatment.
{"title":"Resolución de múltiples nódulos pulmonares cavitados con el abandono del hábito tabáquico como único tratamiento","authors":"M.L. Estévez , C. Pinedo , M. Rodríguez Masi , I. Guerassimova , P. Benedetti , B. Cabeza , G. Rodríguez Trigo","doi":"10.1016/S1576-9895(12)70159-5","DOIUrl":"10.1016/S1576-9895(12)70159-5","url":null,"abstract":"<div><p>The term histiocytosis refers to a heterogeneous group of diseases characterized by the infiltration of Langerhans cells (LC) in different organs. Pulmonary Histiocytosis (PH) is an uncommon disease that typically affects young adults. Its pathogeny is not well known, although a relationship with smoking has been observed. Thus, the first treatment measure should be smoking cessation. We present a case of pulmonary histiocytosis that showed a favorable clinical, functional and radiological course in six months as a consequence of using smoking cessation as the only treatment.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 4","pages":"Pages 140-144"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70159-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56526497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-10-01DOI: 10.1016/S1576-9895(12)70153-4
A. Alonso Arroyo , R. Aleixandre Benavent
{"title":"Importancia para una revista científica de encontrarse incluida en las grandes bases de datos internacionales","authors":"A. Alonso Arroyo , R. Aleixandre Benavent","doi":"10.1016/S1576-9895(12)70153-4","DOIUrl":"10.1016/S1576-9895(12)70153-4","url":null,"abstract":"","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 4","pages":"Pages 101-103"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70153-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-10-01DOI: 10.1016/S1576-9895(12)70157-1
S. Sánchez-Cuéllar, J. Ancochea Bermúdez
Biological markers are being used in the diagnosis and treatment of disease as prevalent as cardiovascular or cancer. Biomarkers are a useful in clinical practice as a non invasive methods for the accurate diagnosis of the disease, monitor disease and create personalized treatment regimes. Asthma is a heterogeneous disease with different phenotypes. Pulmonary function test are most often used to confirm the diagnosis, but not reflect the pathological processes responsible for different phenotypes that present the disease. Inhaled corticosteroids and beta 2 agonists have been mainstay of asthma therapy for over 30 years, but the heterogeneity of the disease means not all asthmatics respond to the same treatment. Biomarkers are useful tools to identify these specific phenotypes. This review focuses on the utility of biomarkers of inflammation of the airway in the management of asthma patients obtained by noninvasive tecniques including sputum, exhaled breath or serum.
{"title":"El uso de los biomarcadores de inflamación en la vía aérea en el manejo del asma","authors":"S. Sánchez-Cuéllar, J. Ancochea Bermúdez","doi":"10.1016/S1576-9895(12)70157-1","DOIUrl":"10.1016/S1576-9895(12)70157-1","url":null,"abstract":"<div><p>Biological markers are being used in the diagnosis and treatment of disease as prevalent as cardiovascular or cancer. Biomarkers are a useful in clinical practice as a non invasive methods for the accurate diagnosis of the disease, monitor disease and create personalized treatment regimes. Asthma is a heterogeneous disease with different phenotypes. Pulmonary function test are most often used to confirm the diagnosis, but not reflect the pathological processes responsible for different phenotypes that present the disease. Inhaled corticosteroids and beta 2 agonists have been mainstay of asthma therapy for over 30 years, but the heterogeneity of the disease means not all asthmatics respond to the same treatment. Biomarkers are useful tools to identify these specific phenotypes. This review focuses on the utility of biomarkers of inflammation of the airway in the management of asthma patients obtained by noninvasive tecniques including sputum, exhaled breath or serum.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 4","pages":"Pages 129-135"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70157-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56526490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-07-01DOI: 10.1016/S1576-9895(12)70149-2
D. Palafox , J. Palafox , G. Aquino , W.L. Dajer-Fadel
Pulmonary benign metastasising leiomyomatosis is an uncommon disease characterized by the presence of pulmonary leiomyomas, in the absence of malignancy criteria in a patient with previous uterin leiomyomatosis. The disease is very uncommon and should be considered amongst the differential diagnosis of pulmonary benign tumors. Due to the challenge that represents to health care providers specialized in respiratory pathology in the diagnosis and management of these type of patients, we present the case of a patient with hysterectomy for uterin myomatosis in which the diagnosis of pulmonary benign metastasising leiomyomatosis was established and treated successfully.
{"title":"Leiomiomatosis benigna pulmonar metastatizante","authors":"D. Palafox , J. Palafox , G. Aquino , W.L. Dajer-Fadel","doi":"10.1016/S1576-9895(12)70149-2","DOIUrl":"10.1016/S1576-9895(12)70149-2","url":null,"abstract":"<div><p>Pulmonary benign metastasising leiomyomatosis is an uncommon disease characterized by the presence of pulmonary leiomyomas, in the absence of malignancy criteria in a patient with previous uterin leiomyomatosis. The disease is very uncommon and should be considered amongst the differential diagnosis of pulmonary benign tumors. Due to the challenge that represents to health care providers specialized in respiratory pathology in the diagnosis and management of these type of patients, we present the case of a patient with hysterectomy for uterin myomatosis in which the diagnosis of pulmonary benign metastasising leiomyomatosis was established and treated successfully.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 3","pages":"Pages 85-88"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70149-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-07-01DOI: 10.1016/S1576-9895(12)70146-7
J.A. Riesco Miranda, M. Torres González, D. del Puerto García
{"title":"Vacuna antineumocócica","authors":"J.A. Riesco Miranda, M. Torres González, D. del Puerto García","doi":"10.1016/S1576-9895(12)70146-7","DOIUrl":"https://doi.org/10.1016/S1576-9895(12)70146-7","url":null,"abstract":"","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 3","pages":"Pages 71-73"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70146-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91622392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-07-01DOI: 10.1016/S1576-9895(12)70147-9
E. Villalobos Pinto, A. Pérez Pérez, J. Cano Fernández, P. Flores Pérez, M. Sánchez–Bayle
Introduction: Invasive pneumococcal disease is one of the diseases with higher morbidity and mortality in children. Despite expectations created, we discuss the role of the heptavalent vaccine in the incidence of complicates pneumonia. Our goal is to determine if it has increased in our hospital.
Patients and methods: We studied 9068 patients admitted with the diagnosis of pneumonia in the Hospital Niño Jesús between 1996 and 2010. A retrospective, observational study, analyzing the total or partial introduction of the vaccine.
Results: Sample segregation in 3 groups according to the non introduction and the total or partial introduction of the vaccine. We confirmed an increase in pleural effusion (p< 0.005) in vaccine groups.
Conclusions: After the introduction of heptavalent pneumococcal vaccine it has been found in our sample an increase in complicated pneumonia with pleural effusion.
{"title":"Derrame pleural en pacientes hospitalizados en la era de la vacuna antineumocócica heptavalente","authors":"E. Villalobos Pinto, A. Pérez Pérez, J. Cano Fernández, P. Flores Pérez, M. Sánchez–Bayle","doi":"10.1016/S1576-9895(12)70147-9","DOIUrl":"10.1016/S1576-9895(12)70147-9","url":null,"abstract":"<div><p><em>Introduction</em>: Invasive pneumococcal disease is one of the diseases with higher morbidity and mortality in children. Despite expectations created, we discuss the role of the heptavalent vaccine in the incidence of complicates pneumonia. Our goal is to determine if it has increased in our hospital.</p><p><em>Patients and methods</em>: We studied 9068 patients admitted with the diagnosis of pneumonia in the Hospital Niño Jesús between 1996 and 2010. A retrospective, observational study, analyzing the total or partial introduction of the vaccine.</p><p><em>Results</em>: Sample segregation in 3 groups according to the non introduction and the total or partial introduction of the vaccine. We confirmed an increase in pleural effusion (p< 0.005) in vaccine groups.</p><p><em>Conclusions</em>: After the introduction of heptavalent pneumococcal vaccine it has been found in our sample an increase in complicated pneumonia with pleural effusion.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 3","pages":"Pages 74-77"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70147-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-07-01DOI: 10.1016/S1576-9895(12)70150-9
I. Martínez Serna, M.A. Mariscal de Alba, F. Hermoso Alarza, R.J. Ávila Martínez, M.C. Marrón Fernández, J.C. Meneses Pardo
Lung hernias are rare entities and are primarily related to chest trauma or previous surgery. Spontaneous lung hernias are even more uncommon. We describe three cases of spontaneous intercostal pulmonary hernia, its evaluation and treatment in all its forms, from the conservative management in small hernias without significant clinical impact, to surgical treatment, either with primary closure of the chest wall or using synthetic mesh in larger hernias or in presence of signs of possible complications.
{"title":"Hernia pulmonar intercostal espontánea secundaria a cuadro de tos","authors":"I. Martínez Serna, M.A. Mariscal de Alba, F. Hermoso Alarza, R.J. Ávila Martínez, M.C. Marrón Fernández, J.C. Meneses Pardo","doi":"10.1016/S1576-9895(12)70150-9","DOIUrl":"10.1016/S1576-9895(12)70150-9","url":null,"abstract":"<div><p>Lung hernias are rare entities and are primarily related to chest trauma or previous surgery. Spontaneous lung hernias are even more uncommon. We describe three cases of spontaneous intercostal pulmonary hernia, its evaluation and treatment in all its forms, from the conservative management in small hernias without significant clinical impact, to surgical treatment, either with primary closure of the chest wall or using synthetic mesh in larger hernias or in presence of signs of possible complications.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 3","pages":"Pages 89-91"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70150-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-07-01DOI: 10.1016/S1576-9895(12)70148-0
L.L. Di Stasi , C. Díaz–Piedra , A. Catena , G. Buela–Casal
Objective: A large consensus exists within the scientific community with regard to the existence of a high incidence of traffic accidents in people with Sleep Apnea Hypopnea Syndrome (SAHS). However, some aspects of this relationship are still in need of clarification. It has not been possible to show the likely cause of this large rate of accidents, there are possible uncontrolled, confounding factors, and some of the evaluation instruments used have low ecological validity. The goal of the study was to analyze risk behavior during driving in patients with SAS, in a virtual reality setting with simulated traffic.
Material and methods: Evaluation of risk driving behavior was carried out using the Honda Riding Trainer simulator. The participants were 12 patients diagnosed with SAS, treated with continuous positive airway pressure (CPAP), and 12 matched controls. Daytime somnolence, mental fatigue, and levels of activation during the tests, were also evaluated in both groups through the use of questionnaires.
Results: Although patients with SAHS showed higher daytime somnolence, they did not exhibit more risk driving behaviors than the control group. There were no differences in mental fatigue or levels of activation during the simulation.
Conclusion: Unlike the results found in classical studies, when the evaluation is carried out with more ecological tools and the duration of the tests is much shorter, the performance of patients with SAS treated with CPAP does not differ from that of the control group. These findings support the use of CPAP as well as the testing of drivers using virtual simulations in order to obtain a driver's license, especially in high risk populations.
{"title":"Conductas de riesgo en pacientes con síndrome de apneas-hipopneas del sueño: estudio exploratorio en situaciones complejas y dinámicas de tráfico simulado","authors":"L.L. Di Stasi , C. Díaz–Piedra , A. Catena , G. Buela–Casal","doi":"10.1016/S1576-9895(12)70148-0","DOIUrl":"10.1016/S1576-9895(12)70148-0","url":null,"abstract":"<div><p><em>Objective</em>: A large consensus exists within the scientific community with regard to the existence of a high incidence of traffic accidents in people with Sleep Apnea Hypopnea Syndrome (SAHS). However, some aspects of this relationship are still in need of clarification. It has not been possible to show the likely cause of this large rate of accidents, there are possible uncontrolled, confounding factors, and some of the evaluation instruments used have low ecological validity. The goal of the study was to analyze risk behavior during driving in patients with SAS, in a virtual reality setting with simulated traffic.</p><p><em>Material and methods</em>: Evaluation of risk driving behavior was carried out using the Honda Riding Trainer simulator. The participants were 12 patients diagnosed with SAS, treated with continuous positive airway pressure (CPAP), and 12 matched controls. Daytime somnolence, mental fatigue, and levels of activation during the tests, were also evaluated in both groups through the use of questionnaires.</p><p><em>Results</em>: Although patients with SAHS showed higher daytime somnolence, they did not exhibit more risk driving behaviors than the control group. There were no differences in mental fatigue or levels of activation during the simulation.</p><p><em>Conclusion</em>: Unlike the results found in classical studies, when the evaluation is carried out with more ecological tools and the duration of the tests is much shorter, the performance of patients with SAS treated with CPAP does not differ from that of the control group. These findings support the use of CPAP as well as the testing of drivers using virtual simulations in order to obtain a driver's license, especially in high risk populations.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 3","pages":"Pages 78-84"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70148-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-04-01DOI: 10.1016/S1576-9895(12)70139-X
R.M. Díaz Campos , R. García Luján , R. Alonso Moralejo , C. García Quero , E. de Miguel Poch
Introduction
The fiberoptic bronchoscopy (FB) is a useful technique in the diagnosis of focal pulmonary nodules and masses. The profitability of the FB and transbronchial biopsy (TB) is variable and depends on different factors such as the operator's experience. The aim of this study was to determine if the diagnostic profitability of these techniques, in the diagnosis of malignant focal pulmonary lesions (FPL), changed with the incorporation of a new medical staff compared with previous data of our center.
Material and methods
A FPL was defined as an intra - parenchymatous pulmonary lesion that is well circumscribed and completely surrounded by healthy lung.
We analyzed all the FBs between 02/2008 and 08/2009 in patients with a FPL with a definitive diagnosis of malignancy. 85 patients were included.
Results
The diagnostic profitability of the TB was 0.55; it was higher when the FPL was > 2 cm (≤ 2 cm vs > 2 cm; 0.38 vs 0.62; p = 0.02) but no difference was found by site (central vs. peripheral; 0.67 vs 0.54; p = 0.16). The previous profitability of TB was 0.76 without differences by size (≤ 2 cm vs > 2 cm; 0.72 vs 0,78; p = 0,48) or site (central vs peripheral; 0.83 vs 0.74; p = 0,39).
Conclusion
We conclude that the operator's experience influences in the diagnostic profitability of the TB, in the malignant FPL.
纤维支气管镜(FB)是诊断局灶性肺结节和肿块的有效技术。FB和经支气管活检(TB)的盈利能力是可变的,取决于不同的因素,如操作员的经验。本研究的目的是确定这些技术在诊断恶性局灶性肺病变(FPL)时的诊断价值是否随着新医务人员的加入而改变,并与本中心以往的数据进行比较。材料与方法FPL被定义为肺实质内病变,被健康肺完全包围。我们分析了2008年2月至2009年8月间确诊为恶性肿瘤的FPL患者的所有FBs。纳入85例患者。结果结核的诊断利润率为0.55;当FPL为>2cm(≤2cm vs >2厘米;0.38 vs 0.62;P = 0.02),但没有发现部位差异(中央vs外周;0.67 vs 0.54;p = 0.16)。TB的先前盈利能力为0.76,没有大小差异(≤2 cm vs >2厘米;0.72 vs 0.78;P = 0,48)或部位(中心vs外围;0.83 vs 0.74;p = 0,39)。结论手术人员的经验对结核病恶性FPL的诊断能力有一定影响。
{"title":"¿Influye la experiencia del operador en la rentabilidad de la broncoscopia en el diagnóstico de lesiones pulmonares focales malignas?","authors":"R.M. Díaz Campos , R. García Luján , R. Alonso Moralejo , C. García Quero , E. de Miguel Poch","doi":"10.1016/S1576-9895(12)70139-X","DOIUrl":"10.1016/S1576-9895(12)70139-X","url":null,"abstract":"<div><h3>Introduction</h3><p>The fiberoptic bronchoscopy (FB) is a useful technique in the diagnosis of focal pulmonary nodules and masses. The profitability of the FB and transbronchial biopsy (TB) is variable and depends on different factors such as the operator's experience. The aim of this study was to determine if the diagnostic profitability of these techniques, in the diagnosis of malignant focal pulmonary lesions (FPL), changed with the incorporation of a new medical staff compared with previous data of our center.</p></div><div><h3>Material and methods</h3><p>A FPL was defined as an intra - parenchymatous pulmonary lesion that is well circumscribed and completely surrounded by healthy lung.</p><p>We analyzed all the FBs between 02/2008 and 08/2009 in patients with a FPL with a definitive diagnosis of malignancy. 85 patients were included.</p></div><div><h3>Results</h3><p>The diagnostic profitability of the TB was 0.55; it was higher when the FPL was > 2<!--> <!-->cm (≤ 2<!--> <!-->cm vs > 2<!--> <!-->cm; 0.38 vs 0.62; p<!--> <!-->=<!--> <!-->0.02) but no difference was found by site (central vs. peripheral; 0.67 vs 0.54; p<!--> <!-->=<!--> <!-->0.16). The previous profitability of TB was 0.76 without differences by size (≤ 2<!--> <!-->cm vs > 2<!--> <!-->cm; 0.72 vs 0,78; p<!--> <!-->=<!--> <!-->0,48) or site (central vs peripheral; 0.83 vs 0.74; p<!--> <!-->=<!--> <!-->0,39).</p></div><div><h3>Conclusion</h3><p>We conclude that the operator's experience influences in the diagnostic profitability of the TB, in the malignant FPL.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 2","pages":"Pages 40-44"},"PeriodicalIF":0.0,"publicationDate":"2012-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70139-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}